Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion type Assertion NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_head.
- NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion description "[Through searching PubMed databases (or hand searching) up to April 2012 using the following MeSH terms and keywords: p53, codon 72 polymorphism and leukemia, or lymphoma, or myeloma, thirteen were identified as eligible articles in this meta-analysis for p53 Arg72Pro polymorphism (2,731 cases and 7, 356 controls), including nine studies on leukemia (1,266 cases and 4, 474 controls), three studies on lymphoma (1,359 cases and 2,652 controls), and one study on myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_provenance.
- NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion evidence source_evidence_literature NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_provenance.
- NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion SIO_000772 23029260 NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_provenance.
- NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion wasDerivedFrom befree-2016 NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_provenance.
- NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_assertion wasGeneratedBy ECO_0000203 NP1017384.RAqbAHO1CkXGl_G6xsWhygbc4_CNeOsQDoG6ULWbCkIKg130_provenance.